Nir Sassi insider trades

Open-market stock purchases and sales by Nir Sassi, Chief Financial Officer at Indaptus Therapeutics, Inc, from SEC Form 4 filings since Sep 13, 2019.

Recent trades

DateStockTradeValue
Dec 22, 2025INDP Indaptus Therapeutics, IncBought (not open market)$54.3K

Companies traded

  • INDP Indaptus Therapeutics, Inc: other filings, last Dec 22, 2025
  • NTEC Intec Pharma Ltd: other filings, last Sep 16, 2020

Get free alerts when Nir Sassi files a new trade →